Skip to main content
. Author manuscript; available in PMC: 2025 Sep 27.
Published in final edited form as: Quintessence Int. 2024 Sep 27;55(8):652–659. doi: 10.3290/j.qi.b5733611

Table 4.

Information routinely provided when referring patients with lesions suspicious for malignancy or premalignancy.

n * (%)
Lesion location 933 87.0
Signs/symptoms 915 85.3
Lesion history 900 83.9
Radiographs 636 59.3
Medical history 543 50.6
Dental history 524 48.8
Photographs 455 42.4
Diagnostic adjunct results, e.g., VELscope 129 12.0
Diagnostic salivary test results 19 1.8
Total 1,073 100
*

the number of GDs indicating that they provide the identified item when making a referral.